VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C5763AA: VAERS reports

33 VAERS reports list lot C5763AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2020-08-31 and 2023-05-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)630%
Injection-site / Local reaction525%
Allergic / Anaphylactic420%
Gastrointestinal315%
Musculoskeletal15%
General / Systemic (non-local)15%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas6
Virginia3
New York3
Florida3
California3
Michigan2
Tennessee2
Colorado2
Hawaii2
Arizona1
Connecticut1
Washington1

Reports by month received

2020-081
2020-091
2020-102
2020-114
2020-121
2021-011
2021-032
2021-043
2021-051
2021-063
2021-071
2021-083
2021-112
2022-021
2022-041
2022-092
2022-101
2022-112
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.